Radio and PodcastRadio and PodcastLive Radio & Podcasts
Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care artwork
Science & Medicine

Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care

Biotech 2050 Podcast by Biotech2050 Podcast

Oct 8, 202500:27:29Science & Medicine

Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two first-in-class oncology drug launches, built entirely through strategic in-licensing and disciplined execution. In this episode, host Alo...

About This Episode

Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two fi...

Podcast

This episode belongs to Biotech 2050 Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Oct 8, 2025, 00:27:29 long, audio available.

Related Episodes

Continue listening to more episodes from Biotech 2050 Podcast.